{"id":8443,"date":"2021-02-07T02:58:42","date_gmt":"2021-02-07T02:58:42","guid":{"rendered":"https:\/\/drvanta.com\/?p=8443"},"modified":"2021-02-10T06:59:13","modified_gmt":"2021-02-10T06:59:13","slug":"dec-20-jan-21-ms-news","status":"publish","type":"post","link":"https:\/\/drvanta.com\/dec-20-jan-21-ms-news\/","title":{"rendered":"DEC 20-JAN 21 MS News- The Benefits of Cinnamon, Green Tea, CBD\/Cannabis, BFR Training & More"},"content":{"rendered":"

\"\"<\/p>\n

COVID 19 & MS<\/strong><\/h3>\n

This new Brazilian  study<\/a> (11,560 people with MS) evaluated  the incidence, clinical outcome, and impact of COVID-19. The results:  the incidence of COVID-19 in  participants with MS was not different from those observed for the general population. The majority (87% ) were mild cases. Most of them were on  MS disease-modifying treatment and continued the treatment during the pandemic. <\/strong><\/h3>\n

\"\"<\/strong><\/h3>\n

Diet & Gut Microbiota <\/strong><\/h3>\n